Trials / Conditions / IIM
IIM
5 registered clinical trials studyying IIM — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Recruiting | AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Ritux NCT06991114 | Artiva Biotherapeutics, Inc. | Phase 2 |
| Recruiting | MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) NCT07374107 | Myositis International Health & Research Collaborative Alliance Foundation | — |
| Recruiting | Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Withdrawn | A Study of RD06-04 in Patients With Active Autoimmune Diseases NCT06548620 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |